Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation
<b>Background</b>: Breast cancer is a leading cause of cancer-related mortality in women. Aspirin, an affordable anti-inflammatory drug, may have anticancer effects, but its impact on survival outcomes after breast cancer diagnosis remains unclear. This meta-analysis evaluates the role o...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/1/44 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841549299117195264 |
|---|---|
| author | Po-Huang Chen Tung-Lung Yang Hong-Jie Jhou Hsu-Lin Lee Ming-Shen Dai |
| author_facet | Po-Huang Chen Tung-Lung Yang Hong-Jie Jhou Hsu-Lin Lee Ming-Shen Dai |
| author_sort | Po-Huang Chen |
| collection | DOAJ |
| description | <b>Background</b>: Breast cancer is a leading cause of cancer-related mortality in women. Aspirin, an affordable anti-inflammatory drug, may have anticancer effects, but its impact on survival outcomes after breast cancer diagnosis remains unclear. This meta-analysis evaluates the role of post-diagnostic aspirin use in breast cancer management. <b>Methods</b>: A systematic review and meta-analysis were conducted using PubMed, EMBASE, and Cochrane Library databases. Twenty studies involving 141,251 participants were included. Survival outcomes assessed were disease-free survival (DFS), overall survival (OS), and breast cancer-specific mortality. Trial sequential analysis (TSA) was used to evaluate the sufficiency of cumulative evidence. <b>Results</b>: Post-diagnostic aspirin use was not significantly associated with DFS (HR: 0.88; 95% CI: 0.69–1.11) or OS (HR: 0.89; 95% CI: 0.74–1.07). However, a significant reduction in breast cancer-specific mortality was observed (HR: 0.77; 95% CI: 0.63–0.93). TSA confirmed that the evidence supporting this association is sufficient. <b>Conclusions</b>: Post-diagnostic aspirin use significantly reduces breast cancer-specific mortality, but it does not improve DFS or OS. These findings underscore the potential therapeutic role of aspirin in breast cancer management. Further randomized controlled trials are needed to validate these results and determine optimal dosing regimens for post-diagnostic use. |
| format | Article |
| id | doaj-art-c5c515cdacf54fba9d86a678204c983b |
| institution | Kabale University |
| issn | 2075-4418 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj-art-c5c515cdacf54fba9d86a678204c983b2025-01-10T13:16:33ZengMDPI AGDiagnostics2075-44182024-12-011514410.3390/diagnostics15010044Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis ValidationPo-Huang Chen0Tung-Lung Yang1Hong-Jie Jhou2Hsu-Lin Lee3Ming-Shen Dai4Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, TaiwanDivision of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, TaiwanDepartment of Neurology, Changhua Christian Hospital, Changhua 500, TaiwanDivision of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, TaiwanDivision of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan<b>Background</b>: Breast cancer is a leading cause of cancer-related mortality in women. Aspirin, an affordable anti-inflammatory drug, may have anticancer effects, but its impact on survival outcomes after breast cancer diagnosis remains unclear. This meta-analysis evaluates the role of post-diagnostic aspirin use in breast cancer management. <b>Methods</b>: A systematic review and meta-analysis were conducted using PubMed, EMBASE, and Cochrane Library databases. Twenty studies involving 141,251 participants were included. Survival outcomes assessed were disease-free survival (DFS), overall survival (OS), and breast cancer-specific mortality. Trial sequential analysis (TSA) was used to evaluate the sufficiency of cumulative evidence. <b>Results</b>: Post-diagnostic aspirin use was not significantly associated with DFS (HR: 0.88; 95% CI: 0.69–1.11) or OS (HR: 0.89; 95% CI: 0.74–1.07). However, a significant reduction in breast cancer-specific mortality was observed (HR: 0.77; 95% CI: 0.63–0.93). TSA confirmed that the evidence supporting this association is sufficient. <b>Conclusions</b>: Post-diagnostic aspirin use significantly reduces breast cancer-specific mortality, but it does not improve DFS or OS. These findings underscore the potential therapeutic role of aspirin in breast cancer management. Further randomized controlled trials are needed to validate these results and determine optimal dosing regimens for post-diagnostic use.https://www.mdpi.com/2075-4418/15/1/44aspirinbreast cancermeta-analysis |
| spellingShingle | Po-Huang Chen Tung-Lung Yang Hong-Jie Jhou Hsu-Lin Lee Ming-Shen Dai Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation Diagnostics aspirin breast cancer meta-analysis |
| title | Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation |
| title_full | Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation |
| title_fullStr | Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation |
| title_full_unstemmed | Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation |
| title_short | Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation |
| title_sort | post diagnostic aspirin use in breast cancer treatment a systematic review and meta analysis of survival outcomes with trial sequential analysis validation |
| topic | aspirin breast cancer meta-analysis |
| url | https://www.mdpi.com/2075-4418/15/1/44 |
| work_keys_str_mv | AT pohuangchen postdiagnosticaspirinuseinbreastcancertreatmentasystematicreviewandmetaanalysisofsurvivaloutcomeswithtrialsequentialanalysisvalidation AT tunglungyang postdiagnosticaspirinuseinbreastcancertreatmentasystematicreviewandmetaanalysisofsurvivaloutcomeswithtrialsequentialanalysisvalidation AT hongjiejhou postdiagnosticaspirinuseinbreastcancertreatmentasystematicreviewandmetaanalysisofsurvivaloutcomeswithtrialsequentialanalysisvalidation AT hsulinlee postdiagnosticaspirinuseinbreastcancertreatmentasystematicreviewandmetaanalysisofsurvivaloutcomeswithtrialsequentialanalysisvalidation AT mingshendai postdiagnosticaspirinuseinbreastcancertreatmentasystematicreviewandmetaanalysisofsurvivaloutcomeswithtrialsequentialanalysisvalidation |